aluates Reports

$ 0.0

Automative

Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-10W13200

Global Pharmaceutical CDMO Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2023

BUY CHAPTERS

Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Research Report 2025

Code: QYRE-Auto-10W13200

Report

May 2025

Pages:131

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Lonza

Catalent

Patheon (Thermo Fisher Scientific)

Aenova

Siegfried

Recipharm

Strides Shasun

Piramal

Metrics

AMRI

Famar

WuXi AppTech

Asymchem

Porton

Amatsigroup

MORAVEK

Ascendia Pharmaceuticals

Ardena

CPL

UPM Pharmaceuticals

FUJIFILM Diosynth Biotechnologies

Groupe Parima

Avid Bioservices

Vetter Pharma

NextPharma

Alcami

NerPharMa

Piramal Pharma Solutions

MedPharm Ltd.

Lundbeck

BioVectra

Pfizer CentreOne

Jubilant Biosys

SEIKAGAKU CORPORATION

Mikart

Adare Pharma Solutions

Fermion

Samsung Biologics

Siegfried Holdings

Boehringer Ingelheim

Jubilant Pharmova Limited

FAREVA SA

AcuraBio

Arranta Bio

TBD Pharmatech

Vetio

Societal CDMO

ten23 health

AGC Pharma Chemicals

Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market

The global market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization).

The Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Report

Report Metric	Details
Report Name	Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market
CAGR	5%
Segment by Type	Intermediate CDMO API CDMO Formulation CDMO Protein CDMO Gene Therapy CDMO Cell Therapy CDMO
Segment by Application	Pharmaceutical Company Biotechnology Company Generic Company Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics, AMRI, Famar, WuXi AppTech, Asymchem, Porton, Amatsigroup, AcuraBio, Moravek, Ascendia Pharmaceuticals, Ardena, CPL, Arranta Bio, UPM Pharmaceuticals, FUJIFILM Diosynth Biotechnologies, Groupe Parima, TBD Pharmatech, Avid Bioservices, Vetter Pharma, NextPharma, Alcami, NerPharMa, Vetio, Societal CDMO, ten23 health, Piramal Pharma Solutions, MedPharm, Lundbeck, AGC Pharma Chemicals, BioVectra, Pfizer CentreOne, Jubilant Biosys, SEIKAGAKU CORPORATION, Mikart, Adare Pharma Solutions, Fermion, Samsung Biologics, Siegfried Holdings, Boehringer Ingelheim, Jubilant Pharmova Limited, Fareva SA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market report?

Ans: The main players in the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market are Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics, AMRI, Famar, WuXi AppTech, Asymchem, Porton, Amatsigroup, AcuraBio, Moravek, Ascendia Pharmaceuticals, Ardena, CPL, Arranta Bio, UPM Pharmaceuticals, FUJIFILM Diosynth Biotechnologies, Groupe Parima, TBD Pharmatech, Avid Bioservices, Vetter Pharma, NextPharma, Alcami, NerPharMa, Vetio, Societal CDMO, ten23 health, Piramal Pharma Solutions, MedPharm, Lundbeck, AGC Pharma Chemicals, BioVectra, Pfizer CentreOne, Jubilant Biosys, SEIKAGAKU CORPORATION, Mikart, Adare Pharma Solutions, Fermion, Samsung Biologics, Siegfried Holdings, Boehringer Ingelheim, Jubilant Pharmova Limited, Fareva SA

What are the Application segmentation covered in the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market report?

Ans: The Applications covered in the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market report are Pharmaceutical Company, Biotechnology Company, Generic Company, Others

What are the Type segmentation covered in the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market report?

Ans: The Types covered in the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market report are Intermediate CDMO, API CDMO, Formulation CDMO, Protein CDMO, Gene Therapy CDMO, Cell Therapy CDMO

Recommended Reports

CDMO Core Services

Drug Types/Modalities

Contract Services Expansion

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Intermediate CDMO

1.2.3 API CDMO

1.2.4 Formulation CDMO

1.2.5 Protein CDMO

1.2.6 Gene Therapy CDMO

1.2.7 Cell Therapy CDMO

1.3 Market by Application

1.3.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Company

1.3.3 Biotechnology Company

1.3.4 Generic Company

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Perspective (2020-2031)

2.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Growth Trends by Region

2.2.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Historic Market Size by Region (2020-2025)

2.2.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Region (2026-2031)

2.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Dynamics

2.3.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Trends

2.3.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers

2.3.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Challenges

2.3.4 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players by Revenue

3.1.1 Global Top Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players by Revenue (2020-2025)

3.1.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Players (2020-2025)

3.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue

3.4 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Concentration Ratio

3.4.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue in 2024

3.5 Global Key Players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Head office and Area Served

3.6 Global Key Players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), Product and Application

3.7 Global Key Players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Breakdown Data by Type

4.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Historic Market Size by Type (2020-2025)

4.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Type (2026-2031)

5 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Breakdown Data by Application

5.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Historic Market Size by Application (2020-2025)

5.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2020-2031)

6.2 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2020-2025)

6.4 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2020-2031)

7.2 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2020-2025)

7.4 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2020-2031)

8.2 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2020-2031)

9.2 Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2020-2025)

9.4 Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2020-2031)

10.2 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza

11.1.1 Lonza Company Details

11.1.2 Lonza Business Overview

11.1.3 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.1.4 Lonza Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.1.5 Lonza Recent Development

11.2 Catalent

11.2.1 Catalent Company Details

11.2.2 Catalent Business Overview

11.2.3 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.2.4 Catalent Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.2.5 Catalent Recent Development

11.3 Patheon (Thermo Fisher Scientific)

11.3.1 Patheon (Thermo Fisher Scientific) Company Details

11.3.2 Patheon (Thermo Fisher Scientific) Business Overview

11.3.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.3.4 Patheon (Thermo Fisher Scientific) Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.3.5 Patheon (Thermo Fisher Scientific) Recent Development

11.4 Aenova

11.4.1 Aenova Company Details

11.4.2 Aenova Business Overview

11.4.3 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.4.4 Aenova Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.4.5 Aenova Recent Development

11.5 Siegfried

11.5.1 Siegfried Company Details

11.5.2 Siegfried Business Overview

11.5.3 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.5.4 Siegfried Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.5.5 Siegfried Recent Development

11.6 Recipharm

11.6.1 Recipharm Company Details

11.6.2 Recipharm Business Overview

11.6.3 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.6.4 Recipharm Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.6.5 Recipharm Recent Development

11.7 Strides Shasun

11.7.1 Strides Shasun Company Details

11.7.2 Strides Shasun Business Overview

11.7.3 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.7.4 Strides Shasun Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.7.5 Strides Shasun Recent Development

11.8 Piramal

11.8.1 Piramal Company Details

11.8.2 Piramal Business Overview

11.8.3 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.8.4 Piramal Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.8.5 Piramal Recent Development

11.9 Metrics

11.9.1 Metrics Company Details

11.9.2 Metrics Business Overview

11.9.3 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.9.4 Metrics Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.9.5 Metrics Recent Development

11.10 AMRI

11.10.1 AMRI Company Details

11.10.2 AMRI Business Overview

11.10.3 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.10.4 AMRI Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.10.5 AMRI Recent Development

11.11 Famar

11.11.1 Famar Company Details

11.11.2 Famar Business Overview

11.11.3 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.11.4 Famar Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.11.5 Famar Recent Development

11.12 WuXi AppTech

11.12.1 WuXi AppTech Company Details

11.12.2 WuXi AppTech Business Overview

11.12.3 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.12.4 WuXi AppTech Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.12.5 WuXi AppTech Recent Development

11.13 Asymchem

11.13.1 Asymchem Company Details

11.13.2 Asymchem Business Overview

11.13.3 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.13.4 Asymchem Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.13.5 Asymchem Recent Development

11.14 Porton

11.14.1 Porton Company Details

11.14.2 Porton Business Overview

11.14.3 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.14.4 Porton Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.14.5 Porton Recent Development

11.15 Amatsigroup

11.15.1 Amatsigroup Company Details

11.15.2 Amatsigroup Business Overview

11.15.3 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.15.4 Amatsigroup Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.15.5 Amatsigroup Recent Development

11.16 AcuraBio

11.16.1 AcuraBio Company Details

11.16.2 AcuraBio Business Overview

11.16.3 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.16.4 AcuraBio Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.16.5 AcuraBio Recent Development

11.17 Moravek

11.17.1 Moravek Company Details

11.17.2 Moravek Business Overview

11.17.3 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.17.4 Moravek Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.17.5 Moravek Recent Development

11.18 Ascendia Pharmaceuticals

11.18.1 Ascendia Pharmaceuticals Company Details

11.18.2 Ascendia Pharmaceuticals Business Overview

11.18.3 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.18.4 Ascendia Pharmaceuticals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.18.5 Ascendia Pharmaceuticals Recent Development

11.19 Ardena

11.19.1 Ardena Company Details

11.19.2 Ardena Business Overview

11.19.3 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.19.4 Ardena Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.19.5 Ardena Recent Development

11.20 CPL

11.20.1 CPL Company Details

11.20.2 CPL Business Overview

11.20.3 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.20.4 CPL Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.20.5 CPL Recent Development

11.21 Arranta Bio

11.21.1 Arranta Bio Company Details

11.21.2 Arranta Bio Business Overview

11.21.3 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.21.4 Arranta Bio Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.21.5 Arranta Bio Recent Development

11.22 UPM Pharmaceuticals

11.22.1 UPM Pharmaceuticals Company Details

11.22.2 UPM Pharmaceuticals Business Overview

11.22.3 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.22.4 UPM Pharmaceuticals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.22.5 UPM Pharmaceuticals Recent Development

11.23 FUJIFILM Diosynth Biotechnologies

11.23.1 FUJIFILM Diosynth Biotechnologies Company Details

11.23.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.23.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.23.4 FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.23.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.24 Groupe Parima

11.24.1 Groupe Parima Company Details

11.24.2 Groupe Parima Business Overview

11.24.3 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.24.4 Groupe Parima Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.24.5 Groupe Parima Recent Development

11.25 TBD Pharmatech

11.25.1 TBD Pharmatech Company Details

11.25.2 TBD Pharmatech Business Overview

11.25.3 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.25.4 TBD Pharmatech Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.25.5 TBD Pharmatech Recent Development

11.26 Avid Bioservices

11.26.1 Avid Bioservices Company Details

11.26.2 Avid Bioservices Business Overview

11.26.3 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.26.4 Avid Bioservices Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.26.5 Avid Bioservices Recent Development

11.27 Vetter Pharma

11.27.1 Vetter Pharma Company Details

11.27.2 Vetter Pharma Business Overview

11.27.3 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.27.4 Vetter Pharma Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.27.5 Vetter Pharma Recent Development

11.28 NextPharma

11.28.1 NextPharma Company Details

11.28.2 NextPharma Business Overview

11.28.3 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.28.4 NextPharma Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.28.5 NextPharma Recent Development

11.29 Alcami

11.29.1 Alcami Company Details

11.29.2 Alcami Business Overview

11.29.3 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.29.4 Alcami Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.29.5 Alcami Recent Development

11.30 NerPharMa

11.30.1 NerPharMa Company Details

11.30.2 NerPharMa Business Overview

11.30.3 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.30.4 NerPharMa Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.30.5 NerPharMa Recent Development

11.31 Vetio

11.31.1 Vetio Company Details

11.31.2 Vetio Business Overview

11.31.3 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.31.4 Vetio Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.31.5 Vetio Recent Development

11.32 Societal CDMO

11.32.1 Societal CDMO Company Details

11.32.2 Societal CDMO Business Overview

11.32.3 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.32.4 Societal CDMO Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.32.5 Societal CDMO Recent Development

11.33 ten23 health

11.33.1 ten23 health Company Details

11.33.2 ten23 health Business Overview

11.33.3 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.33.4 ten23 health Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.33.5 ten23 health Recent Development

11.34 Piramal Pharma Solutions

11.34.1 Piramal Pharma Solutions Company Details

11.34.2 Piramal Pharma Solutions Business Overview

11.34.3 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.34.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.34.5 Piramal Pharma Solutions Recent Development

11.35 MedPharm

11.35.1 MedPharm Company Details

11.35.2 MedPharm Business Overview

11.35.3 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.35.4 MedPharm Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.35.5 MedPharm Recent Development

11.36 Lundbeck

11.36.1 Lundbeck Company Details

11.36.2 Lundbeck Business Overview

11.36.3 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.36.4 Lundbeck Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.36.5 Lundbeck Recent Development

11.37 AGC Pharma Chemicals

11.37.1 AGC Pharma Chemicals Company Details

11.37.2 AGC Pharma Chemicals Business Overview

11.37.3 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.37.4 AGC Pharma Chemicals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.37.5 AGC Pharma Chemicals Recent Development

11.38 BioVectra

11.38.1 BioVectra Company Details

11.38.2 BioVectra Business Overview

11.38.3 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.38.4 BioVectra Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.38.5 BioVectra Recent Development

11.39 Pfizer CentreOne

11.39.1 Pfizer CentreOne Company Details

11.39.2 Pfizer CentreOne Business Overview

11.39.3 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.39.4 Pfizer CentreOne Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.39.5 Pfizer CentreOne Recent Development

11.40 Jubilant Biosys

11.40.1 Jubilant Biosys Company Details

11.40.2 Jubilant Biosys Business Overview

11.40.3 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction

11.40.4 Jubilant Biosys Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

11.40.5 Jubilant Biosys Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Lonza

Catalent

Patheon (Thermo Fisher Scientific)

Aenova

Siegfried

Recipharm

Strides Shasun

Piramal

Metrics

AMRI

Famar

WuXi AppTech

Asymchem

Porton

Amatsigroup

MORAVEK

Ascendia Pharmaceuticals

Ardena

CPL

UPM Pharmaceuticals

FUJIFILM Diosynth Biotechnologies

Groupe Parima

Avid Bioservices

Vetter Pharma

NextPharma

Alcami

NerPharMa

Piramal Pharma Solutions

MedPharm Ltd.

Lundbeck

BioVectra

Pfizer CentreOne

Jubilant Biosys

SEIKAGAKU CORPORATION

Mikart

Adare Pharma Solutions

Fermion

Samsung Biologics

Siegfried Holdings

Boehringer Ingelheim

Jubilant Pharmova Limited

FAREVA SA

AcuraBio

Arranta Bio

TBD Pharmatech

Vetio

Societal CDMO

ten23 health

AGC Pharma Chemicals

List of Tables

Table 1. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Intermediate CDMO

Table 3. Key Players of API CDMO

Table 4. Key Players of Formulation CDMO

Table 5. Key Players of Protein CDMO

Table 6. Key Players of Gene Therapy CDMO

Table 7. Key Players of Cell Therapy CDMO

Table 8. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Region (2020-2025)

Table 12. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Region (2026-2031)

Table 14. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Trends

Table 15. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers

Table 16. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Challenges

Table 17. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Restraints

Table 18. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Players (2020-2025)

Table 20. Global Top Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) as of 2024)

Table 21. Ranking of Global Top Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), Headquarters and Area Served

Table 24. Global Key Players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), Product and Application

Table 25. Global Key Players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Type (2020-2025)

Table 29. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Type (2026-2031)

Table 31. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Application (2020-2025)

Table 33. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Application (2026-2031)

Table 35. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2026-2031) & (US$ Million)

Table 50. Lonza Company Details

Table 51. Lonza Business Overview

Table 52. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 53. Lonza Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 54. Lonza Recent Development

Table 55. Catalent Company Details

Table 56. Catalent Business Overview

Table 57. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 58. Catalent Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 59. Catalent Recent Development

Table 60. Patheon (Thermo Fisher Scientific) Company Details

Table 61. Patheon (Thermo Fisher Scientific) Business Overview

Table 62. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 63. Patheon (Thermo Fisher Scientific) Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 64. Patheon (Thermo Fisher Scientific) Recent Development

Table 65. Aenova Company Details

Table 66. Aenova Business Overview

Table 67. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 68. Aenova Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 69. Aenova Recent Development

Table 70. Siegfried Company Details

Table 71. Siegfried Business Overview

Table 72. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 73. Siegfried Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 74. Siegfried Recent Development

Table 75. Recipharm Company Details

Table 76. Recipharm Business Overview

Table 77. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 78. Recipharm Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 79. Recipharm Recent Development

Table 80. Strides Shasun Company Details

Table 81. Strides Shasun Business Overview

Table 82. Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 83. Strides Shasun Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 84. Strides Shasun Recent Development

Table 85. Piramal Company Details

Table 86. Piramal Business Overview

Table 87. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 88. Piramal Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 89. Piramal Recent Development

Table 90. Metrics Company Details

Table 91. Metrics Business Overview

Table 92. Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 93. Metrics Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 94. Metrics Recent Development

Table 95. AMRI Company Details

Table 96. AMRI Business Overview

Table 97. AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 98. AMRI Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 99. AMRI Recent Development

Table 100. Famar Company Details

Table 101. Famar Business Overview

Table 102. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 103. Famar Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 104. Famar Recent Development

Table 105. WuXi AppTech Company Details

Table 106. WuXi AppTech Business Overview

Table 107. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 108. WuXi AppTech Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 109. WuXi AppTech Recent Development

Table 110. Asymchem Company Details

Table 111. Asymchem Business Overview

Table 112. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 113. Asymchem Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 114. Asymchem Recent Development

Table 115. Porton Company Details

Table 116. Porton Business Overview

Table 117. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 118. Porton Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 119. Porton Recent Development

Table 120. Amatsigroup Company Details

Table 121. Amatsigroup Business Overview

Table 122. Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 123. Amatsigroup Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 124. Amatsigroup Recent Development

Table 125. AcuraBio Company Details

Table 126. AcuraBio Business Overview

Table 127. AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 128. AcuraBio Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 129. AcuraBio Recent Development

Table 130. Moravek Company Details

Table 131. Moravek Business Overview

Table 132. Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 133. Moravek Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 134. Moravek Recent Development

Table 135. Ascendia Pharmaceuticals Company Details

Table 136. Ascendia Pharmaceuticals Business Overview

Table 137. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 138. Ascendia Pharmaceuticals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 139. Ascendia Pharmaceuticals Recent Development

Table 140. Ardena Company Details

Table 141. Ardena Business Overview

Table 142. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 143. Ardena Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 144. Ardena Recent Development

Table 145. CPL Company Details

Table 146. CPL Business Overview

Table 147. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 148. CPL Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 149. CPL Recent Development

Table 150. Arranta Bio Company Details

Table 151. Arranta Bio Business Overview

Table 152. Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 153. Arranta Bio Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 154. Arranta Bio Recent Development

Table 155. UPM Pharmaceuticals Company Details

Table 156. UPM Pharmaceuticals Business Overview

Table 157. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 158. UPM Pharmaceuticals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 159. UPM Pharmaceuticals Recent Development

Table 160. FUJIFILM Diosynth Biotechnologies Company Details

Table 161. FUJIFILM Diosynth Biotechnologies Business Overview

Table 162. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 163. FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 164. FUJIFILM Diosynth Biotechnologies Recent Development

Table 165. Groupe Parima Company Details

Table 166. Groupe Parima Business Overview

Table 167. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 168. Groupe Parima Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 169. Groupe Parima Recent Development

Table 170. TBD Pharmatech Company Details

Table 171. TBD Pharmatech Business Overview

Table 172. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 173. TBD Pharmatech Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 174. TBD Pharmatech Recent Development

Table 175. Avid Bioservices Company Details

Table 176. Avid Bioservices Business Overview

Table 177. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 178. Avid Bioservices Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 179. Avid Bioservices Recent Development

Table 180. Vetter Pharma Company Details

Table 181. Vetter Pharma Business Overview

Table 182. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 183. Vetter Pharma Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 184. Vetter Pharma Recent Development

Table 185. NextPharma Company Details

Table 186. NextPharma Business Overview

Table 187. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 188. NextPharma Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 189. NextPharma Recent Development

Table 190. Alcami Company Details

Table 191. Alcami Business Overview

Table 192. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 193. Alcami Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 194. Alcami Recent Development

Table 195. NerPharMa Company Details

Table 196. NerPharMa Business Overview

Table 197. NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 198. NerPharMa Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 199. NerPharMa Recent Development

Table 200. Vetio Company Details

Table 201. Vetio Business Overview

Table 202. Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 203. Vetio Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 204. Vetio Recent Development

Table 205. Societal CDMO Company Details

Table 206. Societal CDMO Business Overview

Table 207. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 208. Societal CDMO Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 209. Societal CDMO Recent Development

Table 210. ten23 health Company Details

Table 211. ten23 health Business Overview

Table 212. ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 213. ten23 health Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 214. ten23 health Recent Development

Table 215. Piramal Pharma Solutions Company Details

Table 216. Piramal Pharma Solutions Business Overview

Table 217. Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 218. Piramal Pharma Solutions Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 219. Piramal Pharma Solutions Recent Development

Table 220. MedPharm Company Details

Table 221. MedPharm Business Overview

Table 222. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 223. MedPharm Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 224. MedPharm Recent Development

Table 225. Lundbeck Company Details

Table 226. Lundbeck Business Overview

Table 227. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 228. Lundbeck Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 229. Lundbeck Recent Development

Table 230. AGC Pharma Chemicals Company Details

Table 231. AGC Pharma Chemicals Business Overview

Table 232. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 233. AGC Pharma Chemicals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 234. AGC Pharma Chemicals Recent Development

Table 235. BioVectra Company Details

Table 236. BioVectra Business Overview

Table 237. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 238. BioVectra Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 239. BioVectra Recent Development

Table 240. Pfizer CentreOne Company Details

Table 241. Pfizer CentreOne Business Overview

Table 242. Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 243. Pfizer CentreOne Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 244. Pfizer CentreOne Recent Development

Table 245. Jubilant Biosys Company Details

Table 246. Jubilant Biosys Business Overview

Table 247. Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product

Table 248. Jubilant Biosys Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025) & (US$ Million)

Table 249. Jubilant Biosys Recent Development

Table 250. Research Programs/Design for This Report

Table 251. Key Data Information from Secondary Sources

Table 252. Key Data Information from Primary Sources

Table 253. Authors List of This Report

List of Figures

Figure 1. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Picture

Figure 2. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type: 2024 VS 2031

Figure 4. Intermediate CDMO Features

Figure 5. API CDMO Features

Figure 6. Formulation CDMO Features

Figure 7. Protein CDMO Features

Figure 8. Gene Therapy CDMO Features

Figure 9. Cell Therapy CDMO Features

Figure 10. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application: 2024 VS 2031

Figure 12. Pharmaceutical Company Case Studies

Figure 13. Biotechnology Company Case Studies

Figure 14. Generic Company Case Studies

Figure 15. Others Case Studies

Figure 16. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Report Years Considered

Figure 17. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Region: 2024 VS 2031

Figure 20. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Players in 2024

Figure 21. Global Top Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue in 2024

Figure 23. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Country (2020-2031)

Figure 25. United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Country (2020-2031)

Figure 29. Germany Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Region (2020-2031)

Figure 37. China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Country (2020-2031)

Figure 45. Mexico Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Country (2020-2031)

Figure 49. Turkey Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Lonza Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 53. Catalent Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 54. Patheon (Thermo Fisher Scientific) Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 55. Aenova Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 56. Siegfried Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 57. Recipharm Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 58. Strides Shasun Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 59. Piramal Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 60. Metrics Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 61. AMRI Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 62. Famar Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 63. WuXi AppTech Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 64. Asymchem Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2020-2025)

Figure 65. Porton Revenue Growth Rate in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufac

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User